iShares Biotechnology ETF (IBB) News Today $144.36 -3.36 (-2.27%) (As of 11/12/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is WatchingNovember 8, 2024 | msn.comIs the ARKK Fund Ready to Play Nice?October 29, 2024 | investing.comBiotech Stocks About to Make a Seasonal Move Higher? Here's How to Spot a BreakoutOctober 22, 2024 | investing.comIBB: A Near-20x P/E Is Historically Pricey, Technical Trends NeutralOctober 14, 2024 | seekingalpha.comIs Investing in China Like Investing in the US Circa 1950s?October 14, 2024 | investing.comBiotech and Retail ETFs have the highest implied call return according to GoldmanOctober 10, 2024 | seekingalpha.comWatch the Long Bonds for Any Signs of Risk-Off SentimentSeptember 26, 2024 | investing.comiShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.2005September 25, 2024 | msn.comBiotech Boom Ahead? Key Stocks and ETFs to Watch Now (IBB)The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital.September 23, 2024 | marketbeat.comBiotech Breakout: Stocks for Your WatchlistThe iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150.September 12, 2024 | marketbeat.com3 ETFs for Growth Investors to Buy and Hold for DecadesAugust 25, 2024 | fool.comiShares Nasdaq Biotechnology ETF (IBB)August 24, 2024 | uk.finance.yahoo.comSector Update: Health Care Stocks Rise in Late Afternoon TradingAugust 19, 2024 | nasdaq.comDid Retail Stocks and Warren Buffett Save the Market From a Bigger Decline?August 16, 2024 | investing.comSector Update: Health Care Stocks Slipping Late AfternoonAugust 12, 2024 | nasdaq.comDNB MARKETS Upgrades Genmab A (GMAB)August 11, 2024 | msn.comIBB Aug 2024 180.000 callAugust 6, 2024 | hk.finance.yahoo.comIBB Aug 2024 142.000 putAugust 5, 2024 | hk.finance.yahoo.comIBB Aug 2024 125.000 callAugust 4, 2024 | hk.finance.yahoo.comRivian Ramps Up Production: Is Wall Street Overlooking the EV Maker's Potential?July 31, 2024 | investing.comSmall Caps Eye Rebound as Semiconductors Flash Bearish SignalsJuly 25, 2024 | investing.comLong Bonds: Breakout Above July Highs Set to Stoke Recession FearsJuly 23, 2024 | investing.com7 Weekly Charts Indicating Divergent Paths for Key Market SectorsJuly 23, 2024 | investing.comBBH: Buy Rating, As Tech Investors Look Beyond FAANGJuly 23, 2024 | seekingalpha.comSector Update: Health Care Stocks Higher Monday AfternoonJuly 22, 2024 | nasdaq.comCPI Data Sparks Rally in Biotech StocksThe biotech sector has significantly lagged behind the overall market and its leading sector, technology, year-to-date. However, following the release of the CPI data on Thursday, the biotech sector, represented by the iShares Biotechnology ETF NASDAQ: IBB, experienced a significant breakout above a multi-year resistance level.July 15, 2024 | marketbeat.comCPI Data Sparks Rally in Biotech Stocks (IBB)Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market.July 15, 2024 | marketbeat.comBiotech Stocks 2024 Second Half Outlook - Buy BiotechsJuly 9, 2024 | seekingalpha.comAbbVie Stock: A Perfect Dip for Investors to Buy (IBB)ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investorsJuly 3, 2024 | marketbeat.comBiotech Stock Breakout: IBB Eyes Resistance with Amgen and VertexThe biotechnology sector, represented by the iShares Biotechnology ETF NASDAQ: IBB, has experienced a year of consolidation. With the ETF up just 0.8%, it has underperformed the broader market, making it one of the worst-performing sectors year-to-date.July 2, 2024 | marketbeat.comBiotech Stock Breakout: IBB Eyes Resistance with Amgen and VertexThe biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout.July 2, 2024 | marketbeat.comTop Biotech Stocks: Exploring Innovation Opportunities (IBB)One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccinesJune 6, 2024 | marketbeat.comTransportation Stocks Are Selling Off Without a CatalystMay 29, 2024 | investing.comSemiconductors Shine, But Outlook for Other Sectors Remains MixedMay 27, 2024 | investing.comWhy the Rest of 2024 Could Be Good for Investing in Biotech StocksMay 24, 2024 | investorplace.comWill the Biotech Sector Shift From Lagger to Leader?The biotech sector and its popular ETF, the iShares Biotechnology ETF NASDAQ: IBB, have lagged the overall market during the year, with its shares slightly red. However, in recent weeks, the sector has enjoyed a significant rally after bouncing off its uptrend support and now consolidating near several major Simple Moving Averages (SMA).May 10, 2024 | marketbeat.comWill the Biotech Sector Shift From Lagger to Leader? (IBB)The biotech sector has experienced a significant rally after bouncing off uptrend support and is now consolidating near major SMAs.May 10, 2024 | marketbeat.comIGV: The Software ETF Will Eventually Share In The Love We're Now Giving To SemiconductorsMay 10, 2024 | seekingalpha.comRisk On, Risk Off, or Risk Who Knows?May 2, 2024 | investing.comWhen Silver Looks Bad, It’s Usually a Sign of a BottomMay 1, 2024 | investing.comApril Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy MarketApril 30, 2024 | markets.businessinsider.comJune 7th Options Now Available For iShares Trust - iShares Biotechnology ETF (IBB)April 28, 2024 | nasdaq.com9 Best Biotech ETFs for 2024April 19, 2024 | msn.comIBB Crosses Critical Technical IndicatorApril 17, 2024 | nasdaq.comTop 10 best performing S&P 500 health care stocks of 2024April 10, 2024 | msn.comSemiconductors Steady, Biotech Stumbles: What's Next for These Sectors?April 8, 2024 | investing.comBiotech Sector Nears Breakout: Will it Outperform in Q2?The popular iShares Biotechnology ETF NASDAQ: IBB has formed a bullish consolidation in the upper portion of its 52-week range, hinting at a significant sector-wide breakout.April 3, 2024 | marketbeat.comBiotech Sector Nears Breakout: Will it Outperform in Q2? (IBB)The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gainsApril 3, 2024 | marketbeat.comYields Up, US Dollar Up, Junk Bonds Tumble as New Quarter Kicks OffApril 2, 2024 | investing.comPBE: Biotech Could Be Next Big WinnerApril 1, 2024 | seekingalpha.com Get iShares Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here IBB Media Mentions By Week IBB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IBB News Sentiment▼0.290.69▲Average Finance News Sentiment IBB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IBB Articles This Week▼22▲IBB Articles Average Week Get iShares Biotechnology ETF News Delivered to You Automatically Sign up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VanEck Pharmaceutical ETF News Today Invesco S&P SmallCap Health Care ETF News Today ProShares Ultra Nasdaq Biotechnology News Today Invesco Nasdaq Biotechnology ETF News Today ProShares UltraShort Nasdaq Biotechnology News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IBB) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
